CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net revenues	$ 5	$ 61	$ 19	$ 192
Operating expenses
Cost of revenues	1	39	7	108
Research and development, net of settlement of trade debt of $15,000 for the nine months ended September 30, 2012	60	82	209	265
Selling, general and administrative, (net of adjustment of trade debt of $374,000, a reduction in accrued franchise tax of $217,000 and benefit from the liquidation of subsidiaries of $149,000 for the nine months ended September 30, 2013 and net of adjustment of trade debt of $490,000 for the nine months ended September 30, 2012)	275	(136)	217	649
Total operating expenses	336	(15)	433	1,022
Operating (loss) income	(331)	76	(414)	(830)
Other income (expense)
Interest expense - related party	(2)	(59)	(96)	(170)
Interest expense	(2)	(3)	(6)	(9)
Total other income (expense)	(4)	(62)	(102)	(179)
Net (loss) income	(335)	14	(516)	(1,009)
Preferred stock dividend	(67)	(67)	(199)	(199)
Net loss applicable to common stockholders	$ (402)	$ (53)	$ (715)	$ (1,208)
Basic and diluted net loss per common share	$ 0.00	$ 0.00	$ 0.00	$ (0.02)
Basic and diluted weighted average number of common shares outstanding	268,389,553	72,964,624	172,711,623	70,278,553